On The Blog

DEA Extends Telemedicine Prescribing Flexibilities Through 2025

As expected, The Drug Enforcement Administration (DEA) published a new regulation on November 19, 2024, that temporarily extends the COVID-era flexibilities for prescribing controlled substances via telemedicine...

DEA Extends Prescribing Flexibilities Until 2025

The Drug Enforcement Administration (DEA) announced a second extension of the temporary Covid-era exceptions to the Ryan Haight Act requirements for prescribing controlled substances.

DEA Extending Telemedicine Flexibilities Beyond the End of the PHE

DEA Extending Telemedicine Flexibilities Beyond the End of the PHE

PHE Ending: What You Need to Know

PHE Ending: What You Need to Know